Jeffrey Wagner, MD
Clinical Neurophysiology · Englewood, CONPI 1033321914
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,950 of the $9,515 with a category attached, or 62.5%. Viz.ai, Inc. accounts for 62.5% of it on its own, with 10 other manufacturers making up the rest.
Across 19 payments — averaging $500.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viz.ai, Inc.$6K
- Penumbra, Inc.$3K
- AbbVie$163
- Greenwich Biosciences, Inc.$47
- Eisai Inc.$41
- Lundbeck LLC$22
- plus $93 from 5 others
Across 1 payment — averaging $818.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$819
What the payments were for
- Consulting fees$5,95063%
- Speaking & faculty fees$3,20034%
- Food & beverage$3654%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viz.ai, Inc. | 1 | $5,950 |
| Penumbra, Inc. | 1 | $3,200 |
| AbbVie(2 entities) | 7 | $163 |
| Greenwich Biosciences, Inc. | 2 | $47 |
| Eisai Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $22 |
| Amgen | 1 | $21 |
| Pfizer | 1 | $20 |
| Merz North America, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Viz.AI LVO$5,950
- Penumbra System$3,200
How this compares
Too few clinical neurophysiology providers in Coloradoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisone | 12 | $1 |
Paid to pharmacies, not to this prescriber.
Other clinical neurophysiology in Englewood
- Aaron GellerAurora$1K
- Jose Carrau LebronCastle Rock$188
- Craig CarrollLongmont$61
- Kristen BarnerGreeley$24
- Jonathan WoodcockAurora$0
- Alexander WolfDenver$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.